by Madaline Spencer | Apr 23, 2024
Tuan Vu, MD, Professor of Neurology at University of South Florida, discusses myasthenia gravis and results from the Phase 3 CHAMPION clinical trial, testing the safety and efficacy of ravulizumab. Myasthenia gravis (MG) is a chronic autoimmune...
by Madaline Spencer | Apr 19, 2024
The U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug application (IND) for SPG601 for the treatment of Fragile X Syndrome (FXS). Fragile X syndrome is a genetic condition involving changes in part of the X chromosome. FXS...
by Madaline Spencer | Apr 17, 2024
IgA nephropathy is an autoimmune kidney disorder characterized by settlement of immunoglobulin A (IgA), a protein that helps the body fight infections, in the kidneys. This leads to inflammation that makes it difficult for the kidneys to effectively filter blood,...
by Madaline Spencer | Apr 12, 2024
Brahm Goldstein, MD, Vice President, Research and Development, Hematology at CSL Behring, discusses HEMGENIX, a pivotal gene therapy for hemophilia B. Hemophilia B is a bleeding disorder that slows the blood clotting process, caused by genetic changes in...
by Madaline Spencer | Apr 10, 2024
John Charlson, MD, Medical College of Wisconsin, discusses synovial sarcomas and the SPEARHEAD-1 clinical trial testing the safety and efficacy of afami-cel in this rare disease. Synovial sarcoma is a cancer that can originate from different types of...
